Catalent (CTLT) Tops Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. CSX
8. SAP
9. QGEN
10. ELV

Go back to Catalent (CTLT) Tops Q3 EPS by 3c

Catalent, Inc. Reports Third Quarter Fiscal 2019 Results

May 7, 2019 7:30 AM EDT

Q3'19 revenue of $617.5 million decreased 2% as-reported, but increased 2% in constant currency, from Q3'18, while Q3'19 YTD revenue of $1,792.3 million increased 1% as-reported, or 3% in constant currency, from the prior-year period. Double-digit organic segment EBITDA growth within Biologics and Specialty Drug Delivery, Oral Drug Delivery and Clinical Supply Services segments; Juniper acquisition continues to out-perform management expectations. FY'19 financial guidance range tightened. Signed agreement to acquire biologics CDMO Paragon Bioservices,... More